Literature DB >> 1951576

Vulvovaginitis: the role of patient compliance in treatment success.

S A Nixon1.   

Abstract

Vulvovaginitis caused by Candida organisms accounts for a large number of annual office visits to physicians, often for recurrent infection. Despite the availability of many effective antifungal preparations, treatment failures continue to occur because of poor compliance with therapy. Several factors may foster noncompliance. Those involving the patient include denial of illness, misconceptions regarding the nature of the infection or its treatment, a misunderstanding of symptomatic relief versus microbiologic cure, dislike of the dosage form, nonsupport of the sexual consort, or intolerance of side effects. The cost of treatment, inconvenient dosage form, and prolonged duration of therapy may also contribute to noncompliance. This article offers suggestions for optimizing compliance and successful treatment. Two perceived means to this end are improved patient education and the use of short-term therapy in convenient dosage form.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951576     DOI: 10.1016/s0002-9378(12)90728-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Psychological factors associated with recurrent vaginal candidiasis: a preliminary study.

Authors:  G Irving; D Miller; A Robinson; S Reynolds; A J Copas
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

2.  Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis.

Authors:  G E Stein; N Mummaw
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

3.  Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis.

Authors:  M A Lappin; D C Brooker; C A Francisco; J Dorfman
Journal:  Infect Dis Obstet Gynecol       Date:  1996

4.  Systemic vs. topical therapy for the treatment of Vulvovaginal Candidiasis.

Authors:  S Faro
Journal:  Infect Dis Obstet Gynecol       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.